Fourth international symposium - primary systemic treatment in the management of operable breast cancer

Primary systemic antineoplastic treatment is increasingly adopted either in clinical trials or daily routine as a part of the multidisciplinary approach of both operable and locally advanced breast cancer. this treatment modality represents a formidable tool to test in vivo the tumour sensitivity to a selected therapeutic approach, it also allows to explore the interaction between the antineoplastic therapy and the tumour biology, and can provide surrogate parameters of treatment efficacy.the unita' di patologia mammaria breast cancer unit of az. istituti ospitalieri di cremona in collaboration with the university of turin (italy), the university of oxford (united kingdom), the university of melbourne (australia) organises the third international symposium in order to highlight and discuss with leading experts the status of the art and perspectives of primary systemic treatment in the management of breast cancer patients.